General Information of Drug (ID: DM6F8L5)

Drug Name
Clinafloxacin Drug Info
Synonyms Clinafloxacin hydrochloride; AM-1091; PD-127391
Cross-matching ID
PubChem CID
60063
ChEBI ID
CHEMBL94459
CAS Number
CAS 105956-97-6
TTD Drug ID
D00ITG

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Graft-versus-host disease 2.37 0.00e+0 32/42 (76.19%) HLA-DPB1;HLA-DRA;HLA-B;...
Allograft rejection 2.37 0.00e+0 32/38 (84.21%) HLA-DPB1;HLA-DRA;HLA-B;...
Antigen processing and presentation 2.23 0.00e+0 60/78 (76.92%) HSPA8;CD74;HLA-DPB1;...
Type I diabetes mellitus 2.22 0.00e+0 38/43 (88.37%) HLA-DPB1;HLA-DRA;HLA-B;...
Asthma 2.08 0.00e+0 25/31 (80.65%) HLA-DPB1;HLA-DRA;HLA-DQA1;...
Phagosome 2.03 0.00e+0 118/152 (77.63%) TUBB;CD14;HLA-DPB1;...
Autoimmune thyroid disease 1.99 1.76e-3 46/53 (86.79%) HLA-DPB1;HLA-DRA;HLA-B;...
Systemic lupus erythematosus 1.87 6.14e-3 45/135 (33.33%) HLA-DPB1;HLA-DRA;CD86;...
Tuberculosis 1.87 5.46e-3 159/180 (88.33%) CASP10;SRC;CD14;...
Viral myocarditis 1.83 9.83e-3 53/60 (88.33%) HLA-DPB1;HLA-DRA;HLA-B;...
Toll-like receptor signaling pathway 1.80 1.79e-2 94/104 (90.38%) SPP1;CXCL10;CD14;...
Leishmaniasis 1.78 2.05e-2 67/77 (87.01%) HLA-DPB1;HLA-DRA;HLA-DQA1;...
Herpes simplex virus 1 infection 1.75 3.02e-2 165/498 (33.13%) SRC;CD74;HLA-DPB1;...
Primary bile acid biosynthesis 1.72 4.48e-2 15/17 (88.24%) SLC27A5;SCP2;CH25H;...
Toxoplasmosis 1.71 4.42e-2 103/112 (91.96%) HSPA8;HLA-DPB1;BAD;...
Cell adhesion molecules 1.69 4.91e-2 118/148 (79.73%) CD99;HLA-DPB1;HLA-DRA;...
Ascorbate and aldarate metabolism -1.78 4.61e-2 15/30 (50%) UGT2B17;GUSB;UGDH;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 6H, 24H
MDA-MB-231 CVCL_0062 Homo sapiens 0.01uM - 10uM 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.01uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.01uM - 10uM 24H
Liver
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HuH-7 CVCL_0336 Homo sapiens 10uM 72H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.01uM - 10uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H
Umbilical vein
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HUVEC-C CVCL_2959 Homo sapiens 0.04uM - 10uM 24H